AMEX · Medical - Care Facilities

Cryo-Cell International, Inc. (CCEL) Stock

$3.54 +2.31% AMEX: CCEL Healthcare

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States.

Valuation

MetricValue
Price$3.54
Market Cap$28.54M
P/E Ratio-11.76
P/B Ratio-1.57
P/S Ratio0.90
EPS (TTM)$0.00
52-Week High$5.43
52-Week Low$2.72
Dividend Yield17.34%

Financials & Margins

MetricValue
ROE14.18%
ROA-4.06%
ROCE-0.23%
Gross Margin15.63%
Operating Margin15.63%
Net Margin-7.92%
Debt/Equity-0.50
Current Ratio0.60

Annual Financials (USD)

Metric20212022202320242025
Revenue$29.0M$30.0M$31.0M$32.0M$32.0M
Operating Profit$4.0M$4.0M$-12.0M$3.0M$5.0M
Net Profit$2.0M$3.0M$-10.0M$0$-2.0M
EPS$0.25$0.33$-1.14$0.05$-0.30
Op Margin13.9%13.3%-39.3%10.9%15.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$61.0M$65.0M$61.0M$65.0M$62.0M
Total Liabilities$56.0M$66.0M$72.0M$78.0M$80.0M
Cash$8.0M$2.0M$0$1.0M$0
Borrowings$3.0M$12.0M$11.0M$13.0M$12.0M

Latest News

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2026 Financial Results Business Wire · Jul 15, 2026 Cryo-Cell Gets NYSE American Approval for Compliance Plan MT Newswires · May 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$8.0M$9.0M$9.0M$6.0M$5.0M
Investing Cash Flow$-14.0M$-32.0M$-16.0M$-8.0M$-1.0M
Financing Cash Flow$0$-2.0M$-1.0M$-1.0M$0
Net Cash Flow$-2.0M$-7.0M$-1.0M$0$0
Free Cash Flow$1.0M$-9.0M$1.0M$2.0M$5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.50
EV / EBITDA6.76
FCF Yield17.52%
Quick Ratio0.60
Interest Coverage2.50
Return 1Y-27.19%
Return 3Y-40.98%
Return 5Y-52.13%

Ownership

Insiders Held42.03%
Institutions Held13.44%
Institutions Float Held23.19%
Institutional HolderSharesReport Date
SFI Advisors, LLC165,3002026-03-31
Vanguard Capital Management LLC161,5242026-03-31
MassMutual Private Wealth & Trust, FSB111,0352026-06-30
Geode Capital Management, LLC43,6162026-03-31
Vanguard Fiduciary Trust Co23,3462026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Cryo-Cell International, Inc.

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Cryo-Cell International, Inc. is led by CEO David I. Portnoy, employs 82 people, headquartered in US, publicly traded since 1994.

Cryo-Cell International, Inc. (CCEL) stock trades at $3.54 with a market capitalization of $28.54M. The stock is valued at a price-to-earnings (P/E) ratio of -11.76, price-to-book of -1.57, price-to-sales of 0.90. Over the past 52 weeks the stock has ranged between $2.72 and $5.43, and currently trades 34.8% below its 52-week high. It pays a dividend yielding 17.34%.

On profitability, Cryo-Cell International, Inc. generates a return on equity (ROE) of 14.18%, above the typical market average, return on capital employed of -0.23%, an operating margin of 15.63%, a net profit margin of -7.92%.

Official website: www.cryo-cell.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides